No Detail Found!

Effects of low doses of Latrunculins from the Red Sea Marine Sponge Negombata corticata on Intraocular pressure in Normotensive Rabbits

Author(s)
Diaa T. A. Youssef Department Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia; King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
Mohamed M. AlOmmary Department Natural Products, Faculty of Pharmacy, King Abdulaziz University,Jeddah 21589,Saudi Arabia
Aymn T. Abbas Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University,Jeddah 21589,Saudi Arabia
Umama A. Abdel-dayem Animal Facility Unit, King Fahd Medical Research Center, King Abdulaziz University;,Jeddah 21589,Saudi Arabia
Lamiaa A. Shaala Suez Canal University Hospitals, Suez Canal University, Ismailia 41522, Egypt
Yahya A. Alzahrani Drug Information Center, Department of Pharmacy, East Jeddah Hospital, Ministry of Health;,Jeddah,Saudi Arabia
Turki AlZughaibi King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia; Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia
Mostafa E. Rateb School of Computing, Engineering and Physical Sciences, University of the West of Scotland,Paisley PA1 2BE,United Kingdom
Abstract
Latrunculins, C-20 and C-22 macrolides primarily derived from marine sponges of the Negombata genus, exhibit a range of bioactivities, including antitumor, antiviral, antimicrobial, antiangiogenic, and antimigratory effects. In this study, we focused on purifying and identifying Latrunculins from the sponge Negombata corticata and assessing their impact on intraocular pressure (IOP) in normotensive rabbits. Two Latrunculins, latrunculol A (1), and latrunculin A (2), were isolated from the extract of the sponge, and their structures were determined using NMR and (+)-HRESIMS spectral data. The IOPlowering effects of latrunculol A were compared with timolol and latrunculin A. IOP was measured at baseline (0 hours) and at 1, 3, and 24 hours after treatment on both experimental days. The results showed that latrunculol A (0.02%) significantly reduced IOP one hour after administration, with a notable decrease in delta IOP compared to baseline values (p < 0.05) on the first day. This suggests that latrunculol A has a potent IOP-lowering effect in normotensive rabbits. Minimal ocular side effects were observed, indicating a favourable safety profile. These findings highlight latrunculol A as a promising candidate for glaucoma treatment. Its efficacy in reducing IOP, combined with its safety profile, warrants further investigation into its possible application as scaffolds for managing elevated intraocular pressure, a key factor in glaucoma pathogenesis.
Publication Details
Page(s) 34-42
DOI DOI not available
Published Journal: Bioscience Research, Volume: 22, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
IOP lowering effect, latrunculin A, Negombata corticata, macrolides, Red Sea sponge, latrunculol A
References
Abdulsahib WK,Abood SJ .2020 .Effect of digoxin ophthalmic solution on the intraocular pressure in rabbits. Drug Invention Today, 14 : 5-9.
Amagata T,Johnson TA,Cichewicz RH,Tenney K,Mooberry SL,Media J,Edelstein M,Valeriote FA,Crews C. .2008 .Interrogating the bioactive pharmacophore of the latrunculin chemotype by investigating the metabolites of two taxonomically unrelated sponges. J Med Chem, 51 : 7234-7242.
Antunes EM,Copp BR,Davies-Coleman MT,Samaai T. .2005 .Pyrroloiminoquinone and related metabolites from marine sponges. Nat Prod Rep, 22 : 62-72.
HJ Carter,pls XXV .1979 .Contributions to our knowledge of the Spongida. , 3 : 343-360.
Coué M,Brenner SL,Spector I .1987 .Inhibition of actin polymerization by latrunculin A. FEBS Letter, 213 : 316-318.
El Sayed KA,Youssef DTA,Marchetti D. .2006 .Bioactive natural and semisynthetic latrunculins. J Nat Prod, 69 : 219-223.
Groweiss A,Shmueli U,Kashman Y. .1983 .Marine toxins of Latrunculia magnifica. J Org Chem, 48 : 3512-3516.
Hayot C,Debeir O,Van Ham P,Van Damme M,Kiss R,Decaestecker C. .2006 .Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol Appl Pharmacol, 211 : 30-40.
Jacob TF,Singh V,Dixit M,Ginsburg-Shmuel T,Fonseca B,Pintor J,Youdim MBH,Major DT,Weinreb O,Fischer BA O .2018 .Promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist. Purinergic Signal, 14 : 271-284.
Kashman Y,Groweiss A,Shmueli U. .1980 .Latrunculin, a new 2-thiazolidinone macrolide from the marine sponge Latrunculia magnifica. Tetrahedron Lett, 21 : 3629-3632.
Kelly M,Sim-Smith C,Stone R,Samaai T,Reiswig H,Austin W. .2016 .New taxa and arrangements within the family Latrunculiidae (Demospongiae, Poecilosclerida). Zootaxa, 4121 : 1-48.
Khandekar R,Chauhan D,Yasir ZH,Al-Zobidi M,Edward DP .2019 .The prevalence and determinants of glaucoma among 40 years and older Saudi residents in the Riyadh Governorate (except the Capital) - A community based survey. Saudi J Ophthalmol, 33 : 332-337.
MA Laubenfels .1936 .A discussion of the sponge fauna of the Dry Tortugas in particular, and the West Indies in general, with materials for a revision of the families and orders of the Porifera. Tortugas Lab, 467 : 1-225.
Lee LY,Hsu JH,Fu HI,Chen CC,Tung KC .2022 .Lowering the intraocular pressure in rats and rabbits by Cordyceps cicadae extract and its active compounds. Molecules, 27 : 1-13.
Peterson JA,Tian B,Bershadsky AD,Volberg T,Gangnon RE,Spector I,Geiger B,Kaufman PL .1999 .Latrunculin-A increases outflow facility in the monkey. Investig Ophthalmol Vis Sci, 40 : 931-941.
Quigley HA,Broman TA .2006 .The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol, 90 : 262-267.
Rasmussen CA,Kaufman PL,Ritch R,Haque R,Brazzell RK,Vittitow JL .2014 .Latrunculin B reduces intraocular pressure in human ocular hypertension and primary open-angle glaucoma. Transl Vis Sci Technol, 3 : 1.
Samaai T,Gibbons MJ,Kelly M. .2006 .Revision of the genus Latrunculia du Bocage, 1869 (Porifera: Demospongiae: Latrunculiidae) with descriptions of new species from New Caledonia and the Northeastern Pacific. Zootaxa, 1127 : 1-71.
Samaai T,Krasokhin V. .2002 .Latrunculia oparinae n. sp. (Demospongiae, Poecilosclerida, Latrunculiidae) from the Kurile Islands. Russia. Beaufortia, 52 : 95-101.
Spector I,Shochet NR,Kashman Y,Groweiss A. .1983 .Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science, 219 : 493-495.
Tham C,Li X,Wong TY,Quigley HA,Aung T .2014 .Global prevalence of glaucoma and projections of glaucoma burden through 2040: A Systematic review and meta-analysis. Ophthalmology, 121 : 2081-2090.
Wagner IV,Stewart MW,Dorairaj SK .2022 .Updates on the diagnosis and management of glaucoma. Mayo Clin Proc Innov Qual Outcomes, 6 : 618-635.
Weinreb RN,Aung T,Medeiros FA .2014 .The pathophysiology and treatment of glaucoma: a review. JAMA, 311 : 1901-1911.
0

Citations

0

Downloads

47

Views